Details for Patent: 9,387,249
✉ Email this page to a colleague
Which drugs does patent 9,387,249 protect, and when does it expire?
Patent 9,387,249 protects EDARBYCLOR and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 9,387,249
Title: | Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone |
Abstract: | The present invention relates to a method of treating hypertension in a subject or patient needing treatment thereof by administering to said subject or patient at least one angiotensin II receptor blocker in combination with chlorthalidone. |
Inventor(s): | Kupfer; Stuart R. (Deerfield, IL) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Application Number: | 12/644,025 |
Patent Claim Types: see list of patent claims | Use; Dosage form; | More… ↓ |
Drugs Protected by US Patent 9,387,249
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | RX | Yes | No | 9,387,249 | ⤷ Subscribe | TREATMENT OF HYPERTENSION | ⤷ Subscribe | ||||
Azurity | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-002 | Dec 20, 2011 | RX | Yes | Yes | 9,387,249 | ⤷ Subscribe | TREATMENT OF HYPERTENSION | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,387,249
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
World Intellectual Property Organization (WIPO) | 2010075347 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |